Stock Chart

AZN

$184.45 +0.04%
Score: 37.1 AVOID NEW MONEY
LEAPs: SELL $105
i
LEAPs Option Signal

Type: SELL growth_1yr
Strike: $105
Premium: $5.82
Expiry: Jan 15, 2027
Target: $93
Score: -100

LEAPs are long-term options (1+ year) with less time decay.
Pro
Screener
Vol: 0.61x (vs SPY: 0.8x | vs QQQ: 0.8x)
Volume Ratio Explained

Vol: Current volume vs 20-day average
vs SPY: Relative activity vs market
vs QQQ: Relative activity vs tech

Color Guide:
● Red (≥1.5x): High activity
● Yellow (≥1.2x): Above average
● Blue (≤0.7x): Low activity

Interpretation:
• vs SPY > 1: Stock-specific interest
• vs SPY < 1: Stock quiet vs market
Chart Pattern · as of Nov 13, 2026
Bull Pennant weak / forming — below our quality gate quality 57/100
A Bull Pennant is taking shape but hasn't passed our quality gate (60/100), so no projected path or levels are shown — only the forming rails on the chart below.
Historically breaks up 70% of the time (n=1,684). Measured-move targets failed our backtest — none shown.
Technical Chart
CHART OVERLAYS
Active: 2
INDICATORS
TRENDLINES
OPTIONS FLOW
VOLUME & PRICE
OTHER

About AZN - AstraZeneca PLC

A merger between Astra of Sweden and Zeneca Group of the United Kingdom formed AstraZeneca in 1999. The firm sells branded drugs across a number of major therapeutic areas, including oncology (about 40% of total revenue), cardiovascular, renal, and metabolic (25%), rare disease (17%), and respiratory and immunology (15%). The majority of sales comes from international markets, with the United States representing close to one third of its sales.

Key Statistics

Market Cap $286B
P/E Ratio 26.08
Dividend Yield 0.02%

This AZN stock chart provides comprehensive technical analysis including candlestick patterns, volume profile analysis, and options open interest data. Track AZN's price movements with trendlines, gamma walls, and key support/resistance levels.